Last reviewed · How we verify

NCT03916809

EMST in Patients Undergoing CRT for HNCA

Recruiting now NA Last updated 4 December 2024
What this trial tests

NA trial testing EMST in Head and Neck Neoplasms in 30 participants. Currently enrolling.

Timeline
12 July 2017
Primary endpoint
1 August 2025
1 August 2025

Quick facts

Lead sponsorUniversity of Wisconsin, Milwaukee
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment30
Start date12 July 2017
Primary completion1 August 2025
Estimated completion1 August 2025
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Wisconsin, Milwaukee

Who can join

18 and older, any sex, with Head and Neck Neoplasms or Deglutition Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on maintenance of safe and efficient oropharyngeal swallow function in persons with cancer of the head and neck (HNCA) undergoing treatment with radiation therapy or chemoradiotherapy (RT/CRT).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Management of dysphagia in head and neck cancer: current and future perspectives.
    Schellen C, Konings M, Vergauwen A, Van den Steen L, et al · · 2026 · PMID 41939474 · DOI 10.3389/fonc.2026.1799956

Verify or expand the search:

Other trials of EMST

Trials testing the same drug.

Other recruiting trials for Head and Neck Neoplasms

Currently open trials in the same condition.

Other University of Wisconsin, Milwaukee trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03916809.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing